Azurette Kit
Product Images NDC 51862-890

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Azurette (NDC 51862-890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Image-01 (Image 01)
Chemical structure diagrams of desogestrel and ethinyl estradiol. The left diagram depicts the molecular structure of desogestrel with the formula C22H30O. The right diagram shows the molecular structure of ethinyl estradiol with the formula C20H24O2.*
FDA Label Image

Image-02 (Image 02)

Image-02 (Image 02)
A black and white warning label about cigarette smoking and oral contraceptive use. It states that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptives, with higher risk for women over 35 and those who smoke 15 or more cigarettes daily, advising women using oral contraceptives not to smoke.*
FDA Label Image

Image-03 (Image 03)

Image-03 (Image 03)
A bar chart illustrating circulatory disease mortality rates per 100,000 woman-years by age group, smoking status, and oral contraceptive use. Mortality rates are shown for four groups: ever-users and controls, divided by smokers and non-smokers, across age ranges 15-24, 25-34, 35-44, and 45 and older.*
FDA Label Image

Image-04 (Image 04)

Image-04 (Image 04)
A warning text panel about cigarette smoking increasing the risk of serious cardiovascular side effects from oral contraceptive use. It highlights the increased risk with age and heavy smoking (15 or more cigarettes per day), particularly in women over 35 years of age, and advises women using oral contraceptives not to smoke.*
FDA Label Image

Image-05 (Image 05)

Image-05 (Image 05)
Azurette desogestrel/ethinyl estradiol and ethinyl estradiol oral contraceptive kit packaging label. The label shows a blister card with 28 tablets arranged for days of the week from Sunday to Saturday, including 3 dark blue tablets, 2 white tablets, and 5 green tablets. The labeler is Mayne Pharma Inc.*
FDA Label Image

Image-06 (Image 06)

Image-06 (Image 06)
An instructional illustration showing how to select and place the correct day label on a monthly oral contraceptive pill pack for Azurette, a kit containing desogestrel/ethinyl estradiol and ethinyl estradiol. The diagram includes a hand peeling a day label (Monday through Sunday) and placing it on the pack above the pill compartments. Pills are arranged in rows with color coding and arrows indicating the pill-taking sequence.*
FDA Label Image

Image-07 (Image 07)

Image-07 (Image 07)
A warning panel stating that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. It notes the risk is higher with age and heavy smoking (15+ cigarettes/day), especially in women over 35, and advises women using oral contraceptives not to smoke.*
FDA Label Image

Image-08 (Image 08)

Image-08 (Image 08)
Illustration showing a weekly pill schedule for the Azurette kit, depicting dark blue tablets to be taken on specific days and instructions for use. The diagram includes dosage instructions and storage conditions, indicating the 28-tablet blister card arrangement for a monthly cycle.*
FDA Label Image

Image-09 (Image 09)

Image-09 (Image 09)
An instructional illustration demonstrating how to select and place the correct day label on a contraceptive pill kit labeled Azurette. It shows a hand peeling a day label to place above the pill pack, which contains tablets arranged in a grid with days of the week indicated, and includes color-coded pills with usage instructions.*
FDA Label Image

Image-10 (Image 10)

Image-10 (Image 10)
Packaging label for Azurette kit by Mayne Pharma Inc., containing Desogestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP. Each kit includes 6 blister cards of 28 tablets each, with strengths of 0.15 mg/0.02 mg and 0.01 mg. Label includes dosage instructions, storage conditions, warnings, barcodes, and manufacturer information.*
FDA Label Image

Image-11 (Image 11)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.